By ADAM GRIPPINOf the University of Texas& CHRISTIANO MARCONIOf the University of Florida The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally ...

After patient deaths from interstitial lung disease in a lung cancer trial testing the antibody-drug conjugate ifinatamab deruxtecan, the FDA placed a partial hold on Daiichi Sankyo and Merck's global ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

Since that moment, Moderna has taken steps to pave the path to long-term growth -- from cutting costs to focusing on its vast ...

“We’ll stop reflexively searching for a main character, a face for the movement, someone to put on the cover.” “Instead of ...

Missouri’s top prosecutor said China is suing after the state pressed federal officials for help collecting on a roughly $25 ...

Moderna will get $54M from a global coalition for a bird flu mRNA vaccine after the US canceled a $760M deal and cut mRNA ...

Ten of the twelve former Food and Drug Administration (FDA) commissioners and acting commissioners opposed to the Trump ...

The Coalition for Epidemic Preparedness Innovations said it will invest $54.3 million with Moderna to fund a Phase 3 trial of ...

A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

Since he entered politics, President Donald Trump has been a regular on our end-of-year list of the most egregious and ...